Insider · CIK 0001682115

OrbiMed Capital GP VI LLC

CIK 0001682115 Name as filed on the most recent filing

Filed as OrbiMed Capital GP VI LLC (83)

200 transaction lines · from 83 filings · filed 2017-04-27 to 2026-04-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-12-23 S, Open-market sale Verona Pharma plcVRNA 3 lines 49,576,607, disposed Open Form 4 filing 0000947871-22-001257
2022-12-22 S, Open-market sale Verona Pharma plcVRNA 2 lines 86,424,249, disposed Open Form 4 filing 0000947871-22-001257
2022-11-25 P, Open-market purchase scPharmaceuticals Inc.SCPH 4,002,495, acquired Open Form 4 filing 0000947871-22-001214
2022-09-16 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 4,999,999, acquired Open Form 4 filing 0000947871-22-000972
2022-09-12 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 2 lines 4,919,148, disposed Open Form 4 filing 0000947871-22-000964
2022-08-09 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 2,606,713, disposed Open Form 4 filing 0000947871-22-000842
2022-08-08 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 7,857,650, disposed Open Form 4 filing 0000947871-22-000842
2022-06-24 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 803,975, disposed Open Form 4 filing 0000947871-22-000722
2022-06-23 P, Open-market purchase Ikena Oncology, Inc.IKNA 86,884, disposed Open Form 4 filing 0000947871-22-000722
2022-06-22 P, Open-market purchase Ikena Oncology, Inc.IKNA 237,161, disposed Open Form 4 filing 0000947871-22-000722
2022-05-18 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 994,980, acquired Open Form 4 filing 0000947871-22-000629
2022-01-26 S, Open-market sale 89bio, Inc.ETNB 2 lines 180,019, disposed Open Form 4 filing 0000947871-22-000113
2022-01-25 S, Open-market sale 89bio, Inc.ETNB 2 lines 412,364, disposed Open Form 4 filing 0000947871-22-000113
2021-09-17 P, Open-market purchase Alpine Immune Sciences, Inc.ALPN 2 lines 9,499,988, acquired Open Form 4 filing 0000947871-21-001010
2021-07-01 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 1,356,675, disposed Open Form 4 filing 0000947871-21-000753
2021-06-28 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 553,775, disposed Open Form 4 filing 0000947871-21-000737
2021-06-25 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 1,901,517, disposed Open Form 4 filing 0000947871-21-000713
2021-06-24 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 2,914,524, disposed Open Form 4 filing 0000947871-21-000713
2021-06-23 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 8,500, disposed Open Form 4 filing 0000947871-21-000713
2021-06-10 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 2,625,197, disposed Open Form 4 filing 0000947871-21-000702
2021-06-09 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 430,831, disposed Open Form 4 filing 0000947871-21-000682
2021-06-08 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 3,639,579, disposed Open Form 4 filing 0000947871-21-000682
2021-06-07 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 31,498, disposed Open Form 4 filing 0000947871-21-000682
2021-04-21 P, Open-market purchase NeuroPace IncNPCE 3,995,000, acquired Open Form 4 filing 0001209191-21-028199
2021-03-30 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 6,774,400, acquired Open Form 4 filing 0000947871-21-000420
2021-03-30 P, Open-market purchase Ikena Oncology, Inc.IKNA 2 lines 6,774,400, acquired Open Form 4 filing 0000899243-21-014386
2021-03-30 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 2 lines 5,750,000, acquired Open Form 4 filing 0001209191-21-023867
2021-03-30 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 666,905, disposed Open Form 4 filing 0000947871-21-000399
2021-03-29 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,761,187, disposed Open Form 4 filing 0000947871-21-000399
2021-03-26 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 664,246, disposed Open Form 4 filing 0000947871-21-000396
2021-03-25 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,272,618, disposed Open Form 4 filing 0000947871-21-000396
2021-03-24 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 817,383, disposed Open Form 4 filing 0000947871-21-000396
2021-03-23 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 97,085, disposed Open Form 4 filing 0000947871-21-000360
2021-03-22 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 203,104, disposed Open Form 4 filing 0000947871-21-000360
2021-03-19 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 563,149, disposed Open Form 4 filing 0000947871-21-000360
2021-03-18 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 169,834, disposed Open Form 4 filing 0000947871-21-000349
2021-03-17 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 534,200, disposed Open Form 4 filing 0000947871-21-000349
2021-03-16 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,146,305, disposed Open Form 4 filing 0000947871-21-000349
2021-03-15 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2,599,579, disposed Open Form 4 filing 0000947871-21-000334

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP VI LLC, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001682115

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.